Edesa Biotech's total assets for Q2 2026 were $12.38M, a decrease of -15.81% from the previous quarter. EDSA total liabilities were $2.19M for the fiscal quarter, a 189.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.